92 reports

  • TUBERCULOSIS, PNEUMONIA, MRSA, SEPSIS, GLOBAL, PIPELINES BY MOLECULAR TARGET, 2017
  • 4.2.2 MRSA

Acquired Antibiotic Resistance Genes: An Overview.

  • Anti-Infective
  • Antibiotic Resistance
  • Therapy
  • World
  • Deals & Alliance
  • DEVELOPMENT OF ANTIBIOTIC RESISTANCE
  • SPREAD OF ANTIBIOTIC RESISTANCE

About Antibiotics An antibiotic is a chemical compound that kills or slows down the growth of any disease-causing microorganisms such as bacteria, parasite, and fungi but is not effective against viruses and prions. The term "antibiotic" was originally coined to refer to any compound of microbial origin that is antagonistic to...

  • Antibiotic Resistance
  • Allergan plc
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Rising government initiatives to combat antibiotic resistance
  • RISING GOVERNMENT INITIATIVES TO COMBAT ANTIBIOTIC RESISTANCE

About Gonorrhea Therapeutics Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep...

  • Antibiotic Resistance
  • World
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • ANTIBIOTIC RESISTANCE MARKER CARTRIDGE
  • Antibiotic Resistance Marker Cartridge - Product Status

Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, implant and tissue infections; and...

  • Antibiotic Resistance
  • China
  • Europe
  • United States
  • Curetis N.V.
  • ALGORITHM - BACTERIAL ANTIBIOTIC RESISTANCE
  • ALGORITHM - BACTERIAL ANTIBIOTIC RESISTANCE PRODUCT OVERVIEW

Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, swift detection and analysis...

  • Antibiotic Resistance
  • Healthcare
  • Infection Control
  • United States
  • OpGen, Inc.
  • SELECTED COMPANIES MARKETING PCR/NAAT SYNDROMIC TESTS/PANELS FOR INFECTIOUS DISEASES
  • HIV

The PCR testing market, which includes other NAAT technologies, is a large and diverse market. This market consists of three segments: the life science (research) NAAT market, the clinical NAAT market, and an "other" segment that includes forensics, environmental monitoring, veterinary, and other applications that do not involve...

  • Antibiotic Resistance
  • Blood Supply
  • United States
  • World
  • Biocartis S.A.
  • APR 12, 2017: OPGEN TO PRESENT ANTIBIOTIC RESISTANCE PREDICTION DATA AT 25TH EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (ECCMID)
  • OPGEN RAISES USD10 MILLION IN PUBLIC OFFERING OF UNITS

Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, swift detection and analysis...

  • Antibiotic Resistance
  • Medical Device
  • United States
  • Company
  • OpGen, Inc.
  • Apr 06, 2017: Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing

Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, implant and tissue...

  • Antibiotic Resistance
  • Medical Device
  • Germany
  • United States
  • Curetis N.V.
  • Emergence of antibiotic resistance
  • MARKET CHALLENGES

About Microbiology Laboratory Supplies Microbiology laboratory supplies include consumables that are repeatedly and periodically used to test for microbial contamination in products, and to ensure that they are free from this kind of contamination, which can arise at any stage of the product development life cycle. Technavio’s...

  • Antibiotic Resistance
  • Danaher Corporation
  • Merck & Co., Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • 12.3.4 Antibiotic Resistance Patterns
  • ILLUSTRATION DEPICTING THE KEY MECHANISMS OF ANTIBIOTIC RESISTANCE OBSERVED IN GRAM-

PharmaPoint: Healthcare-Associated Gram-Negative Infections - Global Drug Forecast and Market Analysis to 2026 Summary Bacterial infections represent a frequent occurrence in humans. Fortunately, a majority of these infections are successfully eliminated by the native and adaptive immune system. The majority of remaining...

  • Antibiotic Resistance
  • Achaogen, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • The Medicines Company
  • Deal Type
  • EQUITY OFFERING

GlobalData OpGen Inc reported one pharmaceuticals & healthcare deal worth $## million in YTD 2018.

  • Antibiotic Resistance
  • Healthcare
  • United States
  • Company
  • OpGen, Inc.

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P II ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## PC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Dis ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Anti-Infective
  • Antibiotic Resistance
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Synthetic Biologics
  • MOUNTING THREAT OF MICROBIAL ANTIBIOTIC RESISTANCE
  • MOUNTING THREAT OF MICROBIAL ANTIBIOTIC RESISTANCE

World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening and subsegments within. POC and home testing markets for infectious disease are also...

  • Antibiotic Resistance
  • Alere Inc.
  • Cepheid
  • Hologic, Inc.
  • Roche Group
  • JUN 05, 2015: TAXIS PHARMACEUTICALS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING POTENTIAL VIABILITY OF TXA709 IN COMBATING ANTIBIOTIC RESISTANCE
  • APR 27, 2015: TAXIS PHARMACEUTICALS DEMONSTRATES CLINICAL POTENTIAL OF TXA709 IN COMBATING ANTIBIOTIC RESISTANCE

Cell Division Protein FtsZ (ftsz) - Pipeline Review, H2 2017 Summary Cell Division Protein FtsZ (ftsz) - FtsZ is a protein encoded by the ftsZ gene. It is essential cell division protein that forms a contractile ring structure at the future cell division site. The regulation of the ring assembly...

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • 4.6.9 CONCLUSION
  • 2.7.2 MRSA

Antibiotic resistance genes have allowed bacteria to become capable of developing resistance to antibiotics through several mechanisms.

  • Antibiotic Resistance
  • World
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 7.3.3 FRANCE
  • 4.2.2 RESTRAINTS

##.

  • Antibiotic Resistance
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • JUN 05, 2015: TAXIS PHARMACEUTICALS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING POTENTIAL VIABILITY OF TXA709 IN COMBATING ANTIBIOTIC RESISTANCE
  • APR 27, 2015: TAXIS PHARMACEUTICALS DEMONSTRATES CLINICAL POTENTIAL OF TXA709 IN COMBATING ANTIBIOTIC RESISTANCE

Cell Division Protein FtsZ (ftsz) - Pipeline Review, H1 2017 Summary Cell Division Protein FtsZ (ftsz) - FtsZ is a protein encoded by the ftsZ gene. It is essential cell division protein that forms a contractile ring structure at the future cell division site. The regulation of the ring assembly controls the timing...

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • ATLAS IO SYSTEM - BACTERIAL IDENTIFICATION AND ANTIBIOTIC RESISTANCE
  • ATLAS IO SYSTEM - BACTERIAL IDENTIFICATION AND ANTIBIOTIC RESISTANCE - PRODUCT STATUS

Summary Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposable cartridge system, which...

  • Antibiotic Resistance
  • Sexually Transmitted Disease
  • United Kingdom
  • United States
  • GlobalData's company

Q. ##.

  • Antibiotic Resistance
  • North America
  • United States
  • Forecast
  • Thermo Fisher Scientific, Inc.
  • TOSATOXUMAB - DRUG PROFILE

The ERS notes that antibiotic resistance is one of the major threats undermining the treatment of respiratory infections.

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Cempra, Inc.
  • Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Product Development Milestones

" The figures highlighted in Jim O' Neill' s report - and in particular the potential human cost of not addressing antibiotic resistance - are significant.

  • Antibiotic Resistance
  • Hospital
  • World
  • Product Initiative
  • MGB Biopharma Limited

This approach is less susceptible to development of antibiotic resistance, can be used both therapeutically and prophylactically.

  • Antibiotic Resistance
  • Monoclonal Antibody
  • United States
  • World
  • Product Initiative

This approach is less susceptible to development of antibiotic resistance, can be used both therapeutically and prophylactically.

  • Antibiotic Resistance
  • Infectious Disease
  • United States
  • World
  • Product Initiative
  • MRSA DRUGS MARKET IN AMERICAS 2015-2020 ($ BILLIONS)
  • PERCENTAGE OF MRSA INFECTIONS 2014

You can easily book an appointment with one online.

  • Antibiotic Resistance
  • Allergan plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Theravance, Inc.
  • Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Product Development Milestones

" The figures highlighted in Jim O' Neill' s report - and in particular the potential human cost of not addressing antibiotic resistance - are significant.

  • Antibiotic Resistance
  • Hospital
  • World
  • Product Initiative
  • MGB Biopharma Limited
  • ANTIBIOTIC RESISTANCE
  • ANTIBIOTIC RESISTANCE PREVENTION

Abstract • Antibiotics are drugs used to treat infections that are caused by bacteria. • The introduction of antibiotics is recognized as one of the most transformative events in medicine. • Prior to the introduction of the first antibiotics in the 1930s and 1940s, bacterial infections were often fatal, and invasive surgery...

  • Antibiotic Resistance
  • United States
  • Cempra, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SMALL MOLECULE TO INHIBIT DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA AND HIV INTEGRASE FOR HIV AND TUBERCULOSIS - DRUG PROFILE
  • FEATURED NEWS & PRESS RELEASES

SIRTURO also represents an important tool in support of global public health efforts to tackle bacterial resistance to antibiotics.

  • Antibiotic Resistance
  • Tuberculosis
  • Vaccine
  • World
  • TB Drug Development, Inc.
  • Research and Development Brief
  • CF-301 - DRUG PROFILE

Pseudomonas aeruginosa Infections - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pseudomonas aeruginosa Infections - Pipeline Review, H1 2018, provides an overview of the Pseudomonas aeruginosa Infections (Infectious Disease)...

  • Antibiotic Resistance
  • Therapy
  • United States
  • Company
  • Product Initiative

The faster we can tailor therapy, the better things are for the patient and the potential prevention of antibiotic resistance. "

  • Antibiotic Resistance
  • Diagnostics
  • United States
  • Company
  • Accelerate Diagnostics, Inc.
  • SMALL MOLECULES TO INHIBIT LETHAL FACTOR FOR ANTHRAX AND CYSTIC FIBROSIS - DRUG PROFILE
  • ANTHRAX - PIPELINE BY VLP BIOTECH INC, H1 2018

ANTHRAX - PIPELINE BY SOLIGENIX INC, H## 2018 SYNTIRON LLC ANTHRAX - PIPELINE BY SYNTIRON LLC, H## 2018 TETRAPHASE PHARMACEUTICALS INC Tetraphase Pharmaceuticals Inc (Tetraphase) is a pharmaceutical company that discovers and develops antibiotic resistance medicines.

  • Antibiotic Resistance
  • Therapy
  • United States
  • Company
  • Product Initiative